维普中文期刊产品整合服务
44篇 您的检索式:作者名="MESA H"
    题名 作者 年代 出处 被引量
1Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis显示文摘VERSTOVSEK S KANTARJIAN H MESA RA 2010NEnglJMed2010,363,12:1
2Selection for placental efficiency in swine : Genetic parameters and trends 显示文摘MESA H SAFRANSI TJ FISCHER KA 2005Journal of ani- mal science2005,85,:1
3The effect of testing temperature on corrosion resistance of martensitie stainless steals 显示文摘Mesa D H Tora A Sinatora A 2003Wear2003,255,:1
4Isolation by distance in the Atlantic cod, Gadus morhua, at large and small geographic scales 显示文摘Pogson G H Taggart C T Mesa K A 2001Evolution2001,55,1:1
5The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M 2010Science2010,330,6010:1
6Formation of a liquid crystalline phase in the water-sodium taurodeoxycholate system显示文摘EDLUND H KHAN A MESA C L 0,,13:1
7Anticoagulation for atrial fibrillation: underutilization in a Brazilian tertiary outpatient clinic 显示文摘Mesas C E Veloso H H De Paola A A 2004Clin Cardiol2004,27,11:1
8Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis显示文摘Verstovsek S Kantarjian H Mesa RA 2010N Engl J Med2010,363,:1
9Evaluating the serial use of the myelofibrosis symptom assessment form for measuring symp- tomatic improvement显示文摘Mesa RA Kantarjian H Tefferi A 2011Cancer2011,117,:1
10The effect of testing temperature on corrosion-erosion resistance of martensitic stainless steels 显示文摘Mesa D H Toro A Sinatora A 2003Wear2003,255,:1
11The effect of testing temperature on corrosion-erosion resistance of martensitic stainless steels 显示文摘Mesa D H Toro A Sinatora A 2003Wear2003,255,16:1
12Safety and efficacy of INCB018424,a JAK1 and JAK2 inhibitor,in myelofibrosis显示文摘Verstovsek S Kantarjian H Mesa RA 2010NEnglJ Med2010,363,12:1
13The effect of testing temperature on corrosion-erosion resistance of martensitic stainless steels显示文摘Mesa D H Toro A Sinatora A Tschiptschin A P 2003Wear2003,255,:1
14Dispersion relation of electromagnetic wave in one-dimensional plasma photonic crystals显示文摘HOJO H MESA A 2004J Plasma Fusion Res2004,80,20:1
15Liquid crystals and phase equilibria binary bile salt-water systems显示文摘Eduardo F Marques Edlund H Mesa C L 2000Langmuir2000,16,11:1
16De Marco Formula effectiveness as an adjunctive therapy to prevent infected ischemic diabetic foot amputation and reduce plasma fibrinogen显示文摘Milagros García Mesa Héctor álvarez Duarte José Hernández Carretero Martha M. Fors López Miriam Mahia Vilas 2010Journal of Tissue Viability2010,,2:1
17Safety and efficacy of INCB018424,a JAK1 and JAK2 inhibitor, in myelofibrosis 显示文摘Verstovsek S Kantarjian H Mesa RA 2010N Engl J Med2010,363,12:1
18JAK2(V617F) and leukemic transformation in myelofibrosis with myetoid metaplasia 显示文摘Mesa RA Powell H Lasho T 2006Leuk Res2006,30,11:1
19Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis 显示文摘VERSTOVSEK S KANTARJIAN H MESA R A 2010N Engl J Med2010,363,12:1
20JAK2 (V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia显示文摘MESA R A POWELL H LASHO T 2006Leuk Res2006,30,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费